Pathomechanisms of Neurodegeneration in Glutaryl-CoA Dehydrogenase Deficiency

Annals of Neurology

Volumn 55, Issue 1, 2004, Pages 7-12

  Kölker, Stefan ^a   Koeller, David M ^b   Okun, Jürgen G ^a   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYGLUTARIC ACID; 3-HYDROXYGLUTARIC ACID; CARBOXYLIC ACID DERIVATIVE; CREATINE PHOSPHATE; CYTOKINE; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLUTARIC ACID; GLUTARIC ACID DERIVATIVE; GLUTARYL COENZYME A DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ACIDEMIA; ACUTE DISEASE; ANIMAL; AUTOSOMAL RECESSIVE DISORDER; BIOLOGICAL MODEL; BRAIN DEVELOPMENT; CELL DAMAGE; CORPUS STRIATUM; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DYSKINESIA; DYSTONIA; ENERGY METABOLISM; FEVER; GABAERGIC SYSTEM; GENE EXPRESSION; GLUTARYL COENZYME A DEHYDROGENASE DEFICIENCY; HUMAN; INFANT; METABOLIC ENCEPHALOPATHY; METABOLISM; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUTRITIONAL DEFICIENCY; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; URINARY EXCRETION;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BRAIN DISEASES, METABOLIC, INBORN; CHILD, PRESCHOOL; GLUTARATES; GLUTARYL-COA DEHYDROGENASE; HUMANS; INFANT; MODELS, NEUROLOGICAL; NERVE DEGENERATION; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS;

EID: 0347319252     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10784     Document Type: Review

References (62)

1. Goodman SI, Markey SP, Moe PG, et al. Glutaric aciduria: a "new" disorder of amino acid metabolism. Biochem Med 1975;12:12-21.
2. Kyllerman M, Steen G. Glutaric aciduria: a common metabolic disorder. Arch Fr Pediatr 1980;37:279.
3. Biery BJ, Stein BE, Morton DH, Goodman SI. Gene structure and mutations of glutaryl-coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet 1996;59:1006-1011.
4. Haworth JC, Booth FA, Chudley AE, et al. Phenotypic variability in glutaric aciduria type. I: Report of fourteen cases in five Canadian Indian kindreds. J Pediatr 1991;118:52-58.
5. Greenberg CR, Reimer D, Singal R, et al. A G-to-T transversion at the +5 position of intron 1 in glutaryl CoA dehydrogenase gene is associated with the Island Lake variant of glutaric acidemia type I. Hum Mol Genet 1995;4:493-495.
6. Greenberg CR, Duncan AM, Gregory CA, et al. Assignment of human glutaryl-CoA dehydrogenase gene (GCDH) to the short arm of chromosome 19 (19p13.2) by in situ hybridization and somatic cell hybrid analysis. Genomics 1994;21:289-290.
7. Goodman SI, Kratz LE, DiGiulio KA, et al. Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes in Escherichia coli. Hum Mol Genet 1995;4:1493-1498.
8. 3H-labelled glutaryl-CoA: application in the genotyping of the glutaryl-CoA dehydrogenase locus. Clin Chim Acta 1993;220:71-80.
9. Goodman SI, Stein DE, Schlesinger S, et al. Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat 1998;12:141-144.
10. Busquets C, Merinero B, Christensen E, et al. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 2000;48:315-322.
11. Zschocke J, Quak E, Guldberg P, Hoffmann GF. Mutation analysis in glutaric aciduria type I. J Med Genet 2000;37:177-181.
12. Baric I, Wagner L, Feyh P, et al. Sensitivity and specificity of free and total glutaric and 3-hydroxyglutaric acids measurements by stable isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 1999;22:867-881.
13. Meyburg J, Schulze A, Kohlmüller D, et al. Postnatal changes in neonatal acylcarnitne profile. Pediatr Res 2001;49:125-129.
14. Hoffmann GF, Trefz KH, Barth P, et al. Glutaryl-CoA dehydrogenase deficiency: a distinct encephalopathy. Pediatrics 1991;88:1194-1203.
15. Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996;]27:115-123.
16. Morton DH, Bennett MJ, Sergeant LE, et al. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Gen 1991;41:89-95.
17. Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severiry of motor impairment and clinical outcome of glutaric acidemia type I. J Pediatr 2000;137:681-686.
18. Iafolla AK, Kahler SG. Megalencephaly in the neonatal period as the initial manifestation of glutaric aciduria type I. J Pediatr 1989;114:1004-1006.
19. Hoffmann GF, Trefz KH, Barth P, et al. Macrocephaly: an important indication for organic acid analysis. J Inherit Metab Dis 1991;14:329-332.
20. Amir N, Elpeleg ON, Shalev RS, Christensen E. Glutaric aciduria type I: clinical heterogeneity and neuroradiologic features. Neurology 1987;37:1654-1657.
21. Brismar J, Ozand PT, CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. Am J Neuroradiol 1995;16:675-683.
22. Forstner R, Hoffmann GF, Gassner I, et al., Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr Radiol 1999;29:138-143.
23. Monavari AA, Naughten ER. Prevention of cerebral palsy in glutaric aciduria type I by dietary management. Arch Dis Child 2000;82:67-70.
24. Kölker, S, Ramaekers VT, Zschocke J, Hoffmann GF. Acute encephalopathy despite early therapy in a patient with homozygosity for E365K in the glutaryl-CoA dehydrogenase gene. J Pediatr 2001;138:277-279.
25. Bäht O, Mader I, Zschocke J, et al. Adult onset glutaric aciduria type I presenting with leukoencephalopathy, Neurology 2002;59:1802-1804.
26. Nyhan WL, Zschocke J, Hoffmann GF, et al. Glutau, I-Glutaryl-CoA dehydrogenase deficiency presenting as 3-hydroxyglutaric aciduria. Mol Genet Metab 1999;66:199-204.
27. Stokke O, Goodman SI, Moe PG. Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and β-hydroxyglutarate: explanation of the symptoms in glutaric aciduria? Clin Chim Acta 1976;66:411-415.
28. Bennett JP, Logan WJ, Snyder SH. Amino acids as central nervous transmitters: the influence of ions, amino acid analogues, and ontogeny on transport systems for L-glutamic and L-aspartic acids and glycine into central nervous synaptosomes of the rat. J Neurochem 1973;21:1533-1550.
29. Schwarcz R, Whetsell WO, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983;219:316-318.
30. Heyes MP. Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I. Can J Neurol Sci 1987;14:441-443.
31. Goodman SI, Norenberg MD, Shikes RH, et al. Glutaric aciduria: biochemical and morphological considerations. J Pediatr 1977;90:746-750.
32. Leibel RL, Shih VE, Goodman SI, et al. Glutaric acidemia: a metabolic disorder causing progressive choreoathethosis. Neurology 1980;30:1163-1168.
33. Chow CW, Haan EA, Goodman SI, et al. Neuropathology of glutaric acidaemia type I. Acta Neuropathol 1988;76:590-594.
34. Kölker S, Schor DSM, Feyh P, et al. Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 2003;34:253-260.
35. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970;227:609-610.
36. Flott-Rahmel B, Falter C, Schluff P, et al. Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis 1997;20:387-390.
37. Ullrich K, Flott-Rahmel B, Schluff P, et al. Glutaric aciduria type I: pathomechanism of neurodegeneration. J Inherit Metab Dis 1999;22:392-403.
38. Bjugstad KB, Zawada WM, Goodman SI, Freed CR. IGF-1 and bFGF reduced glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis 2001;24:631-647.
39. KöIker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis 1999;22:259-262.
40. KöIker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res 2000;47:495-503.
41. Kölker S, Ahlemeyer B, Hühne R, et al. Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci 2001;13:2115-2122.
42. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 2001;50:76-82.
43. De Mello CF, Kölker S, Ahlemeyer B, et al. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and excitotoxic lesions in rats. Brain Res 2001;916:70-75.
44. Kölker S, Okun JG, Ahlemeyer B, et al. Chronic treatment with glutaric acid induces partial tolerance to excitotoxiciry in cultures from chick embryo telencephalon. J Neurosci Res 2002;68:424-431.
45. + dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 2002;52:199-206.
46. Latini A, Borba Rosa R, Scussiato K, et al. 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res 2002;956:367-373.
47. De Oliveira Marques F, Hagen ME, Pederzolli CD, et al. Glutaric acid induces oxidative stress in brain of young rats. Brain Res 2003;964:153-158.
48. Das AM, Lücke T, Ullrich K. Glutaric aciduria type I: creatine supplementation restores creatinephosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol Gen Metab 2003;78:108-111.
49. Dawson VL, Kizushi VM, Huang PL, et al. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 1996;16:2476-2487.
50. Hewett SJ, Csernansky CA, Choi DW. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994;13:487-494.
51. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. Evaluation of trigger factors of acute encephalopathy in glutaric aciduria type I: fever and tumour necrosis factor-α. J Inherit Metab Dis 1999;23:359-362.
52. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1427-C1437.
53. Lima TTF, Begnini J, de Bastiani J, et al. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res 1998;802:55-60.
54. Gegelashvili G, Shousboe A. High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol 1997;52:5-15.
55. 3H] glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J Neurol Sci 2000;173:93-96.
56. Resink A, Villa M, Benke D, et al. Characterization of agonist-induced downregulation of NMDA receptors in cerebellar granule cell cultures. J Neurochem 1996;66:369-377.
57. Cebers G, Cebere A, Wagner A, et al. Prolonged inhibition of glutamate reuptake downregulates NMDA receptor functions in cultured cerebellar granule cells. J Neurochem 1999;72:2181-2190.
58. Woontner M, Crnic LS, Koeller DM. Analysis of the expression of murine glutaryl-CoA dehydrogenase: in vitro and in vivo studies. Mol Genet Metab 2000;69:116-122.
59. Koeller DM, Woontner M, Crnic LS, et al. Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 2002;11:347-357.
60. Soffer D, Amir N, Elpeleg ON, et al. Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci 1992;107:199-204.
61. McMillan TA, Gibson KM, Sweetman L, et al. Conservation of central nervous system glutaryl-coenzyme A dehydrogenase in fruit-eating bats with glutaric aciduria and deficient hepatic glutaryl-coenzyme A dehydrogenase. J Biol Chem 1988;263:17258-17261.
62. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet 2003;121C:38-52.